To operate or not?: A literature review of surgical outcomes in 95 patients with Parkinson's disease undergoing spine surgery.

Sarkiss CA, Fogg GA, Skovrlj B, Cho SK, Caridi JM.

Clin Neurol Neurosurg. 2015 Jul;134:122-5. doi: 10.1016/j.clineuro.2015.04.022. Review.

Disability is an Independent Predictor of Falls and Recurrent Falls in People with Parkinson's Disease Without a History of Falls: A One-Year Prospective Study.

Almeida LR, Sherrington C, Allen NE, Paul SS, Valenca GT, Oliveira-Filho J, Canning CG.

J Parkinsons Dis. 2015;5(4):855-64. doi: 10.3233/JPD-150651.

Cardiocirculatory manifestations in Parkinson's disease patients without orthostatic hypotension.

Pérez T, Tijero B, Gabilondo I, Luna A, Llorens V, Berganzo K, Acera M, Gonzalez A, Sanchez-Ferro A, Lezcano E, Zarranz JJ, Gómez-Esteban JC.

J Hum Hypertens. 2015 Oct;29(10):604-9. doi: 10.1038/jhh.2014.131.

Propofol requirement for induction of unconsciousness is reduced in patients with Parkinson's disease: a case control study.

Xu XP, Yu XY, Wu X, Hu XW, Chen JC, Li JB, Wang JF, Deng XM.

Biomed Res Int. 2015;2015:953729. doi: 10.1155/2015/953729.

To rise and to fall: functional connectivity in cognitively normal and cognitively impaired patients with Parkinson's disease.

Gorges M, Müller HP, Lulé D; LANDSCAPE Consortium., Pinkhardt EH, Ludolph AC, Kassubek J.

Neurobiol Aging. 2015 Apr;36(4):1727-35. doi: 10.1016/j.neurobiolaging.2014.12.026.

Intervention with exercise restores motor deficits but not nigrostriatal loss in a progressive MPTP mouse model of Parkinson's disease.

Sconce MD, Churchill MJ, Greene RE, Meshul CK.

Neuroscience. 2015 Jul 23;299:156-74. doi: 10.1016/j.neuroscience.2015.04.069.

Hypometabolism in Posterior and Temporal Areas of the Brain is Associated with Cognitive Decline in Parkinson's Disease.

Tard C, Demailly F, Delval A, Semah F, Defebvre L, Dujardin K, Moreau C.

J Parkinsons Dis. 2015;5(3):569-74. doi: 10.3233/JPD-150583.

[Parkinson's disease and psychoses].

Bizzarri JV, Giupponi G, Maniscalco I, Schroffenegger P, Conca A, Kapfhammer HP.

Neuropsychiatr. 2015;29(1):1-13. doi: 10.1007/s40211-014-0132-8. Review. German.

Topographical Distribution of Morphological Changes in a Partial Model of Parkinson's Disease--Effects of Nanoencapsulated Neurotrophic Factors Administration.

Requejo C, Ruiz-Ortega JA, Bengoetxea H, Garcia-Blanco A, Herrán E, Aristieta A, Igartua M, Ugedo L, Pedraz JL, Hernández RM, Lafuente JV.

Mol Neurobiol. 2015 Oct;52(2):846-58. doi: 10.1007/s12035-015-9234-y.

Analysis of Parkinson's disease pathophysiology using an integrated genomics-bioinformatics approach.

Fu LM, Fu KA.

Pathophysiology. 2015 Mar;22(1):15-29. doi: 10.1016/j.pathophys.2014.10.002.

Association of TLR4 gene polymorphisms with sporadic Parkinson's disease in a Han Chinese population.

Zhao J, Han X, Xue L, Zhu K, Liu H, Xie A.

Neurol Sci. 2015 Sep;36(9):1659-65. doi: 10.1007/s10072-015-2227-9.

Longitudinal study of normal cognition in Parkinson disease.

Pigott K, Rick J, Xie SX, Hurtig H, Chen-Plotkin A, Duda JE, Morley JF, Chahine LM, Dahodwala N, Akhtar RS, Siderowf A, Trojanowski JQ, Weintraub D.

Neurology. 2015 Oct 13;85(15):1276-82. doi: 10.1212/WNL.0000000000002001.

Thinking about motor fluctuations: An examination of metacognitions in Parkinson's disease.

Fernie BA, Spada MM, Ray Chaudhuri K, Klingelhoefer L, Brown RG.

J Psychosom Res. 2015 Dec;79(6):669-73. doi: 10.1016/j.jpsychores.2015.05.001.

Agomelatine for Depression in Parkinson Disease: Additional Effect on Sleep and Motor Dysfunction.

Avila A, Cardona X, Martin-Baranera M, Leon L, Caballol N, Millet P, Bello J.

J Clin Psychopharmacol. 2015 Dec;35(6):719-23. doi: 10.1097/JCP.0000000000000404.

Neuroprotective effects of the cultivated Chondrus crispus in a C. elegans model of Parkinson's disease.

Liu J, Banskota AH, Critchley AT, Hafting J, Prithiviraj B.

Mar Drugs. 2015 Apr 14;13(4):2250-66. doi: 10.3390/md13042250.